APOC3 and atherosclerosis: More importantly, our data support the concept that apoC-III ASO treatment in conjunction with cholesterol lowering and diet intervention can further halt progression of atherosclerosis and advanced plaque rupture, providing an additional treatment paradigm for patients who have HTG and increased CVD risk.